Fingolimod for Multiple Sclerosis | NEJM
Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis | SpringerLink
Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis | Semantic Scholar
The mechanism of action of glatiramer acetate in multiple sclerosis and beyond - ScienceDirect
Sphingosine-1-phosphate Receptor Modulators in Multiple Sclerosis | touchNEUROLOGY
From Natural Product to the First Oral Treatment for Multiple Sclerosis: The Discovery of FTY720 (Gilenya™)? - ScienceDirect
Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action - The Lancet Neurology
Mechanism of action of Fingolimod | Download Scientific Diagram
Frontiers | Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke | Neurology
A Mechanistically Novel, First Oral Therapy for Multiple Sclerosis: The Development of Fingolimod (FTY720, Gilenya) - Jerold Chun - Discovery Medicine
Multiple sclerosis | Neurology Clinical Practice
Current immunotherapies for multiple sclerosis and neuromyelitis optica spectrum disorders: the similarities and differences
Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy - ScienceDirect
Simplified overview of postulated mechanism of action of standard... | Download Scientific Diagram
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis | SpringerLink
Emerging multiple sclerosis oral therapies | Semantic Scholar
Glatiramer Acetate Treatment of Multiple Sclerosis: An Immunological Perspective | The Journal of Immunology
Monoclonal Antibody Therapy in Multiple Sclerosis - Practical Neurology
Teriflunomide and Its Mechanism of Action in Multiple Sclerosis | SpringerLink
Emerging multiple sclerosis oral therapies | Neurology
Frontiers | Multiple Sclerosis, Relapses, and the Mechanism of Action of Adrenocorticotropic Hormone | Neurology
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery
